Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
January 04 2021 - 12:18PM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare
company, today announced Chairman and Chief Executive Officer Al
Altomari will participate in a fireside chat at the H.C. Wainwright
BIOCONNECT 2021 Virtual Conference.
The fireside chat will be available for on-demand listening
beginning Monday, January 11, 2021, at 6:00 AM Eastern
Time on the Investors section of the Agile Therapeutics
website at www.agiletherapeutics.com, under the Events &
Presentations tab. The archived webcast will be available for
30 days.
About Agile Therapeutics, Inc.Agile
Therapeutics is a women's healthcare company dedicated to
fulfilling the unmet health needs of today’s women. Our
product candidates are designed to provide women with contraceptive
options that offer freedom from taking a daily pill, without
committing to a longer-acting method. Our initial product,
Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system
is a non-daily prescription contraceptive. Twirla is based on our
proprietary transdermal patch technology, called Skinfusion®, which
is designed to allow drug delivery through the skin. For more
information, please visit the company website
at www.agiletherapeutics.com. The Company may
occasionally disseminate material, nonpublic information on the
Company’s website.
Follow Agile on LinkedIn and
Twitter: @AgileTher.
Contact: Matt RileyHead of Investor
Relations & Corporate
Communicationsmriley@agiletherapeutics.com
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Sep 2023 to Sep 2024